Affinage

SFXN4

Sideroflexin-4 · UniProt Q6P4A7

Length
337 aa
Mass
38.0 kDa
Annotated
2026-04-28
22 papers in source corpus 8 papers cited in narrative 8 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

SFXN4 is a mitochondrial inner membrane protein that functions at the intersection of iron-sulfur (Fe-S) cluster biogenesis and respiratory chain complex I assembly. It acts as a complex I assembly factor by interacting with the MCIA complex to enable assembly of the ND2 module, and its loss causes severe complex I deficiency in patient tissues and cell lines (PMID:35333655, PMID:31059822). SFXN4 is also essential for cellular Fe-S cluster biogenesis, with knockout reducing Fe-S protein stability, disrupting the cytosolic aconitase–IRP1 iron-sensing switch, redistributing iron to mitochondria, impairing ferrochelatase-dependent heme synthesis, and sensitizing cells to oxidative stress and DNA repair defects (PMID:31873120, PMID:36402786). Biallelic loss-of-function mutations in SFXN4 cause mitochondrial disease characterized by complex I deficiency and macrocytic anemia, recapitulated by zebrafish knockdown (PMID:24119684).

Mechanistic history

Synthesis pass · year-by-year structured walk · 7 steps
  1. 2003 Medium

    Initial cloning established that SFXN4 encodes a five-transmembrane-domain protein broadly expressed across human tissues and homologous to sideroflexin family members linked to sideroblastic anemia, providing the first structural and genomic characterization.

    Evidence cDNA cloning from human fetal brain, genomic mapping, RT-PCR, and transmembrane topology prediction

    PMID:14756423

    Open questions at the time
    • No functional assay performed
    • Transmembrane topology based on prediction only
    • No direct link to a physiological process
  2. 2013 High

    The first disease association demonstrated that SFXN4 localizes to the mitochondrial inner membrane, is required for mitochondrial respiratory homeostasis, and that its loss causes macrocytic anemia, establishing SFXN4 as a mitochondrial disease gene.

    Evidence Patient fibroblast complementation, zebrafish sfxn4 knockdown with respiratory chain assays and hematopoiesis phenotyping

    PMID:24119684

    Open questions at the time
    • Molecular mechanism underlying respiratory chain deficiency unknown
    • Which respiratory complexes are affected was not resolved
    • Direct protein interaction partners not identified
  3. 2019 High

    Functional studies revealed that SFXN4 is essential for Fe-S cluster biogenesis, explaining the downstream effects on respiratory chain complexes, the aconitase–IRP1 iron-sensing switch, iron redistribution, ferrochelatase stability, and ALAS2 translation-dependent heme synthesis.

    Evidence SFXN4 knockout/knockdown in cell lines with Fe-S cluster assays, aconitase activity, iron redistribution, ferrochelatase and ALAS2 translation, and respiration measurements

    PMID:31873120

    Open questions at the time
    • Whether SFXN4 acts directly in Fe-S cluster assembly or indirectly via substrate transport was unresolved
    • Relationship between Fe-S biogenesis role and complex I assembly not delineated
  4. 2019 Medium

    A patient case with biallelic SFXN4 mutations confirmed that complex I is the predominant respiratory chain complex affected, with severe loss of complex I activity and subunit proteins in muscle tissue.

    Evidence Muscle mitochondrial enzyme assays, immunoblotting for complex I subunits, whole-exome sequencing, mRNA expression analysis

    PMID:31059822

    Open questions at the time
    • Single patient case
    • Mechanism of selective complex I vulnerability not addressed
    • Other tissue types not examined
  5. 2022 High

    The direct molecular mechanism was resolved: SFXN4 physically interacts with the MCIA complex and is specifically required for assembly of the ND2 module of complex I, directly explaining why its loss causes complex I deficiency.

    Evidence Co-immunoprecipitation, complexome profiling, and functional assembly assays

    PMID:35333655

    Open questions at the time
    • Whether the Fe-S cluster biogenesis role is separable from or upstream of the MCIA interaction is unclear
    • Structural basis of the SFXN4–MCIA interaction unknown
    • Whether SFXN4 transports a substrate required for ND2 module assembly is untested
  6. 2022 High

    SFXN4's Fe-S biogenesis function was shown to extend to DNA repair: its loss impairs Fe-S-dependent DNA repair enzymes, causes iron accumulation and oxidative stress, and sensitizes ovarian cancer cells to cisplatin and PARP inhibitors, with knockout inhibiting tumor growth in vivo.

    Evidence siRNA/CRISPR knockout with Fe-S cluster assays, iron measurement, DNA repair assays, drug sensitivity assays, and mouse xenograft

    PMID:36402786

    Open questions at the time
    • Whether the DNA repair sensitization phenotype is generalizable beyond ovarian cancer cells
    • Direct measurement of Fe-S loading on specific repair enzymes not performed
    • Clinical relevance as therapeutic target unvalidated
  7. 2023 Medium

    Complexome profiling in CLPP-deficient mice revealed SFXN4 co-accumulation with COX15 at the inner membrane alongside heavy metal accumulation, suggesting a broader role in respiratory complex assembly or metal homeostasis beyond complex I.

    Evidence Mitochondrial complexome profiling across three mouse tissues with immunoblot validation

    PMID:38139332

    Open questions at the time
    • SFXN4 role in complex IV assembly inferred from co-migration, not functionally tested
    • Observed in a CLPP-null background which may not reflect normal physiology
    • Causal relationship between SFXN4 accumulation and heavy metal changes unestablished

Open questions

Synthesis pass · forward-looking unresolved questions
  • It remains unresolved whether SFXN4's Fe-S cluster biogenesis function and its MCIA complex interaction for ND2 module assembly represent a single mechanistic pathway or two separable activities, and whether SFXN4 acts as a transporter of an iron-containing substrate across the inner mitochondrial membrane.
  • No substrate for SFXN4 transport identified
  • No structural model of SFXN4 or its MCIA interaction
  • Relationship between Fe-S biogenesis and complex I assembly factor functions not mechanistically separated

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Localization
GO:0005739 mitochondrion 5
Pathway
R-HSA-1430728 Metabolism 3 R-HSA-1643685 Disease 2
Complex memberships
MCIA complex (interactor)

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2013 SFXN4 localizes to the mitochondrial inner membrane and is required for mitochondrial respiratory homeostasis and erythropoiesis, as demonstrated by patient fibroblast complementation studies and zebrafish knockdown recapitulating respiratory defects and macrocytic anemia. In vitro complementation in patient fibroblasts, zebrafish sfxn4 knockdown with respiratory chain functional assays and hematopoiesis phenotyping American journal of human genetics High 24119684
2019 SFXN4 is essential for Fe-S cluster biogenesis; its knockout reduces stability and activity of cellular Fe-S proteins, diminishes mitochondrial respiratory chain complexes, causes a shift to glycolytic metabolism, influences the cytosolic aconitase-IRP1 switch, redistributes iron from cytosol to mitochondria, and reduces ferrochelatase levels and inhibits ALAS2 translation, thereby impacting heme synthesis. SFXN4 knockout and knockdown in cell lines with Fe-S cluster functional assays, aconitase activity assays, iron redistribution measurements, ferrochelatase and ALAS2 translation analysis, mitochondrial respiration assays Scientific reports High 31873120
2022 SFXN4 is a complex I assembly factor that interacts with the MCIA complex and is specifically required for assembly of the ND2 module of complex I; this mechanistically explains why SFXN4 mutations cause mitochondrial disease. Co-immunoprecipitation, complexome profiling, and functional assembly assays demonstrating interaction with the MCIA complex and loss of ND2 module assembly Proceedings of the National Academy of Sciences of the United States of America High 35333655
2019 Patient with novel bi-allelic SFXN4 mutations showed severe deficiency of complex I enzyme activity and loss of complex I subunit proteins in muscle, with loss of SFXN4 transcripts confirmed by expression analysis, establishing that SFXN4 is specifically required for complex I activity in vivo. Muscle mitochondrial enzyme activity assays, immunoblotting for complex I subunits, whole-exome sequencing, mRNA expression analysis Mitochondrion Medium 31059822
2022 SFXN4 knockdown in ovarian cancer cells inhibits Fe-S cluster biogenesis, leading to excess iron accumulation and oxidative stress, and impairs Fe-S-dependent DNA repair enzymes, thereby sensitizing cells to cisplatin and PARP inhibitors; SFXN4 knockout profoundly inhibits tumor growth in a mouse ovarian cancer metastasis model. SFXN4 siRNA knockdown and CRISPR knockout with Fe-S cluster assays, iron measurement, DNA repair assays, drug sensitivity assays (cisplatin, olaparib), and in vivo mouse xenograft model Scientific reports High 36402786
2023 In CLPP-deficient mouse tissues, SFXN4 accumulates together with complex IV assembly factors COX15 at the mitochondrial inner membrane, suggesting SFXN4 participates in complex IV assembly or metal homeostasis, with accompanying increases in heavy metal levels (iron, molybdenum, cobalt, manganese). Mitochondrial complexome profiling (complexomics) across three mouse tissues, validated by immunoblot International journal of molecular sciences Medium 38139332
2003 SFXN4 encodes a 305-amino-acid protein with a conserved predicted five-transmembrane-domain structure mapped to chromosome 10q25-26, expressed in many tissues, and homologous to mouse sideroflexin proteins associated with sideroblastic anemia. cDNA cloning from human fetal brain library, genomic mapping, RT-PCR tissue expression, transmembrane topology prediction DNA sequence : the journal of DNA sequencing and mapping Medium 14756423
2025 SFXN2 and SFXN4 are implicated in mitochondrial iron regulation, heme biosynthesis, and iron-sulfur cluster assembly, with conserved transmembrane domains and key motifs critical for substrate transport and mitochondrial iron homeostasis across eukaryotic evolution. Comparative genomics, evolutionary analysis, and literature synthesis of family functional data Human genomics Low 40542427

Source papers

Stage 0 corpus · 22 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2013 Macrocytic anemia and mitochondriopathy resulting from a defect in sideroflexin 4. American journal of human genetics 56 24119684
2019 Sideroflexin 4 affects Fe-S cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymes. Scientific reports 42 31873120
2020 Genome-Wide Association Study Meta-Analysis of Stroke in 22 000 Individuals of African Descent Identifies Novel Associations With Stroke. Stroke 28 32693751
2022 Sideroflexin 4 is a complex I assembly factor that interacts with the MCIA complex and is required for the assembly of the ND2 module. Proceedings of the National Academy of Sciences of the United States of America 22 35333655
2003 Molecular cloning and characterization of a novel human putative transmembrane protein homologous to mouse sideroflexin associated with sideroblastic anemia. DNA sequence : the journal of DNA sequencing and mapping 20 14756423
2021 Trait correlated expression combined with eQTL and ASE analyses identified novel candidate genes affecting intramuscular fat. BMC genomics 17 34749647
2022 Hereditary myopathies associated with hematological abnormalities. Muscle & nerve 11 34985130
2019 [Prenatal onset of mitochondrial disease is associated with sideroflexin 4 deficiency]. Mitochondrion 10 31059822
2023 Comprehensive Analysis of Sideroflexin 4 in Hepatocellular Carcinoma by Bioinformatics and Experiments. International journal of medical sciences 8 37786439
2022 Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer. Scientific reports 8 36402786
2020 Interactome networks between the human respiratory syncytial virus (HRSV), the human metapneumovirus (ΗMPV), and their host: In silico investigation and comparative functional enrichment analysis. Microbial pathogenesis 7 31988005
2023 Translation Fidelity and Respiration Deficits in CLPP-Deficient Tissues: Mechanistic Insights from Mitochondrial Complexome Profiling. International journal of molecular sciences 5 38139332
2025 Update of the sideroflexin (SLC56) gene family. Human genomics 4 40542427
2022 Screening and Analysis of Potential Critical Gene in Acute Myocardial Infarction Based on a miRNA-mRNA Regulatory Network. International journal of general medicine 4 35300139
2021 Transcriptome-wide Association Study Identifies Genetically Dysregulated Genes in Diabetic Neuropathy. Combinatorial chemistry & high throughput screening 4 32772906
2025 Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers. Human genomics 2 39915876
2024 Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary Disease. Clinical proteomics 2 38355435
2025 Multi-omics integrative analysis reveals novel genetic loci and candidate genes for ischemic stroke. Molecular therapy. Nucleic acids 1 40777745
2026 Phenotypic description and functional characterization of the mitochondrial disease associated with the SFXN4 gene. Mitochondrion 0 41713566
2025 Dynamic changes in lactate-related genes in microglia and their role in immune cell interactions after ischemic stroke. Open medicine (Warsaw, Poland) 0 40292254
2025 Expression and Clinical Significance of Sideroflexin 4 (SFXN4) in Colorectal Cancer. In vivo (Athens, Greece) 0 41167676
2025 Construction and validation of an oxidative phosphorylation-related gene signature in lung squamous cell carcinoma patients. Lung cancer management 0 41343408